Positron emission tomography (PET): An update on applications in breast cancer

Richard L. Wahl

Research output: Contribution to journalArticlepeer-review

Abstract

Positron Emission Tomography (PET) is an imaging method which detects alterations in tumor physiology and displays them in an anatomically precise manner. Historically, the method has been a research tool, but it is being increasingly applied to clinical imaging problems. PET, using the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG), has been applied most widely and shows promise in detecting primary cancers, characterizing breast masses, staging for axillary metastases, evaluating for systemic metastases, and following response to therapy. This review summarizes the current status of this technique, which is in rapid evolution as new tracers and new imaging cameras become available.

Original languageEnglish (US)
Pages (from-to)165-175
Number of pages11
JournalBreast Disease
Volume10
Issue number3-4
DOIs
StatePublished - Aug 1998

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Positron emission tomography (PET): An update on applications in breast cancer'. Together they form a unique fingerprint.

Cite this